Tags

Type your tag names separated by a space and hit enter

Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?
Neurochem Res. 2010 Aug; 35(8):1206-13.NR

Abstract

The study aimed to investigate the involvement of nitric oxide (NO) in maneb (MB)- and paraquat (PQ)-induced Parkinson's disease (PD) phenotype in mouse and its subsequent contribution to lipid peroxidation. Animals were treated intraperitoneally with or without MB and PQ, twice a week for 3, 6 and 9 weeks. In some sets of experiments (9 weeks treated groups), the animals were treated intraperitoneally with or without inducible nitric oxide synthase (iNOS) inhibitor-aminoguanidine, tyrosine kinase inhibitor-genistein, nuclear factor-kappa B (NF-kB) inhibitor-pyrrolidine dithiocarbamate (PDTC) or p38 mitogen activated protein kinase (MAPK) inhibitor-SB202190. Nitrite content and lipid peroxidation were measured in all treated groups along with respective controls. RNA was isolated from the striatum of control and treated mice and reverse transcribed into cDNA. RT-PCR was performed to amplify iNOS mRNA and western blot analysis was done to check its protein level. MB- and PQ-treatment induced nitrite content, expressions of iNOS mRNA and protein and lipid peroxidation as compared with respective controls. Aminoguanidine resulted in a significant attenuation of iNOS mRNA expression, nitrite content and lipid peroxidation demonstrating the involvement of nitric oxide in MB- and PQ-induced lipid peroxidation. Genistein, SB202190 and PDTC reduced the expression of iNOS mRNA, nitrite content and lipid peroxidation in MB- and PQ-treated mouse striatum. The results obtained demonstrate that nitric oxide contributes to an increase of MB- and PQ-induced lipid peroxidation in mouse striatum and tyrosine kinase, p38 MAPK and NF-kB regulate iNOS expression.

Authors+Show Affiliations

Indian Institute of Toxicology Research (Council of Scientific and Industrial Research), Mahatma Gandhi Marg, Lucknow, UP, India.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20455021

Citation

Gupta, Satya Prakash, et al. "Involvement of Nitric Oxide in Maneb- and Paraquat-induced Parkinson's Disease Phenotype in Mouse: Is There Any Link With Lipid Peroxidation?" Neurochemical Research, vol. 35, no. 8, 2010, pp. 1206-13.
Gupta SP, Patel S, Yadav S, et al. Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation? Neurochem Res. 2010;35(8):1206-13.
Gupta, S. P., Patel, S., Yadav, S., Singh, A. K., Singh, S., & Singh, M. P. (2010). Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation? Neurochemical Research, 35(8), 1206-13. https://doi.org/10.1007/s11064-010-0176-5
Gupta SP, et al. Involvement of Nitric Oxide in Maneb- and Paraquat-induced Parkinson's Disease Phenotype in Mouse: Is There Any Link With Lipid Peroxidation. Neurochem Res. 2010;35(8):1206-13. PubMed PMID: 20455021.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation? AU - Gupta,Satya Prakash, AU - Patel,Suman, AU - Yadav,Sharawan, AU - Singh,Anand Kumar, AU - Singh,Seema, AU - Singh,Mahendra Pratap, Y1 - 2010/05/09/ PY - 2010/04/17/accepted PY - 2010/5/11/entrez PY - 2010/5/11/pubmed PY - 2010/9/8/medline SP - 1206 EP - 13 JF - Neurochemical research JO - Neurochem Res VL - 35 IS - 8 N2 - The study aimed to investigate the involvement of nitric oxide (NO) in maneb (MB)- and paraquat (PQ)-induced Parkinson's disease (PD) phenotype in mouse and its subsequent contribution to lipid peroxidation. Animals were treated intraperitoneally with or without MB and PQ, twice a week for 3, 6 and 9 weeks. In some sets of experiments (9 weeks treated groups), the animals were treated intraperitoneally with or without inducible nitric oxide synthase (iNOS) inhibitor-aminoguanidine, tyrosine kinase inhibitor-genistein, nuclear factor-kappa B (NF-kB) inhibitor-pyrrolidine dithiocarbamate (PDTC) or p38 mitogen activated protein kinase (MAPK) inhibitor-SB202190. Nitrite content and lipid peroxidation were measured in all treated groups along with respective controls. RNA was isolated from the striatum of control and treated mice and reverse transcribed into cDNA. RT-PCR was performed to amplify iNOS mRNA and western blot analysis was done to check its protein level. MB- and PQ-treatment induced nitrite content, expressions of iNOS mRNA and protein and lipid peroxidation as compared with respective controls. Aminoguanidine resulted in a significant attenuation of iNOS mRNA expression, nitrite content and lipid peroxidation demonstrating the involvement of nitric oxide in MB- and PQ-induced lipid peroxidation. Genistein, SB202190 and PDTC reduced the expression of iNOS mRNA, nitrite content and lipid peroxidation in MB- and PQ-treated mouse striatum. The results obtained demonstrate that nitric oxide contributes to an increase of MB- and PQ-induced lipid peroxidation in mouse striatum and tyrosine kinase, p38 MAPK and NF-kB regulate iNOS expression. SN - 1573-6903 UR - https://www.unboundmedicine.com/medline/citation/20455021/Involvement_of_nitric_oxide_in_maneb__and_paraquat_induced_Parkinson's_disease_phenotype_in_mouse:_is_there_any_link_with_lipid_peroxidation L2 - https://doi.org/10.1007/s11064-010-0176-5 DB - PRIME DP - Unbound Medicine ER -